Found 26 matching trials
Efficacy and Safety of Brodalumab Compared With Guselkumab in the Treatment of Plaque Psoriasis After Inadequate Response to Ustekinumab PHASE4 The trial investigates the efficacy and safety of brodalumab against guselk...
Show More Location
LEO Pharma Investigational Site
Learn More & Join Trial
Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis PHASE3 The purpose of the study is to evaluate the efficacy, safety, pharmacokinet...
Show More Location
Renstar Medical Research
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis PHASE3 The primary purpose of this study is to evaluate the efficacy of guselkumab...
Show More Location
Rheumatology Associates
Learn More & Join Trial
A Study of Ixekizumab (LY2439821) Compared to Guselkumab in Participants With Moderate-to-Severe Plaque Psoriasis PHASE4 The purpose of this study is to compare the efficacy and safety of ixekizum...
Show More Location
Total Skin and Beauty Dermatology Center PC
Learn More & Join Trial
A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis PHASE3 The purpose of this study is to evaluate the efficacy of guselkumab for the...
Show More Location
CHU Bordeaux - Hopital St Andre
Learn More & Join Trial
A Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis PHASE3 The purpose of this study is to evaluate the efficacy, safety, and tolerabi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety of Guselkumab in Participants With Palmoplantar Pustulosis PHASE3 The purpose of this study is to evaluate the efficacy and safety of guselku...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s) PHASE3 The primary purpose of this study is to evaluate the efficacy of guselkumab...
Show More Location
Rheumatology Associates
Learn More & Join Trial
A Study to Evaluate Guselkumab for the Treatment of Participants With New-onset or Relapsing Giant Cell Arteritis PHASE2 The primary purpose of this study is to evaluate the efficacy of guselkumab...
Show More Location
University of Kansas Medical Center
Learn More & Join Trial
Study of Guselkumab in Skin of Color Participants With Moderate-to-severe Plaque and/or Scalp Psoriasis PHASE3 The purpose of this study is to evaluate the efficacy of guselkumab treatme...
Show More Location
Total Skin and Beauty Dermatology Center
Learn More & Join Trial